A pioneering study, the Elevated Childhood Lead Interagency Prevalence Study (ECLIPS), has launched in Leeds to screen children aged 1–6 for lead exposure using home-based finger‑prick blood tests, soil and dust sampling, and surveys.
UCSF researchers report a new spatial repellent that provides up to one year of protection against malaria and other mosquito-borne diseases, marking the first WHO-endorsed vector control tool in over four decades.
A new multi-omics AI model combines cfDNA and cfRNA to predict preterm birth risk with nearly 90% accuracy, offering promising insights for maternal health.
Murdoch Children’s Research Institute launches an international trial of a 21-valent pneumococcal vaccine to protect babies against pneumonia, meningitis, and sepsis.
A new study links excessive screen time in children and teens to higher risks of high blood pressure, cholesterol, and insulin resistance, especially when sleep is limited.
The NHS will offer a long-acting antibody injection to protect thousands of premature and vulnerable babies from respiratory syncytial virus (RSV) starting this autumn.
The NHS will provide a new triple combination therapy to hundreds of children and adults with cystic fibrosis in England, aiming to improve lung function and quality of life for eligible patients.
A first-in-patient trial using AAV-based OTOF gene therapy, led by Karolinska Institutet and Chinese hospitals, restored hearing (improving from 106 dB to 52 dB) in 10 individuals aged 1–24.
A Stanford-led phase 3 trial shows gene therapy skin grafts significantly heal chronic wounds in patients with severe epidermolysis bullosa, reducing pain and improving quality of life.
Around 20,000 children and young people with type 1 diabetes in England now benefit from life-changing 'artificial pancreas' technology, recommended by NICE.
